This Informatica Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Jefferies analyst Andrew Tsai downgraded the rating for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) from Buy to Hold and lowered the price target from $29 to $2.5. Rocket Pharmaceuticals shares closed at $2.33 on Tuesday. See how other analysts view this stock.
• Wolfe Research analyst Alex Zukin downgraded the rating for Informatica Inc. (NYSE:INFA) from Outperform to Peer Perform. Informatica shares closed at $23.92 on Tuesday. See how other analysts view this stock.
• Wells Fargo analyst Finian O’Shea downgraded Runway Growth Finance Corp. (NASDAQ:RWAY) from Overweight to Equal-Weight and lowered the price target from $10 to $9.5. Runway Growth Finance shares closed at $9.83 on Tuesday. See how other analysts view this stock.

Considering buying INFA stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Says Rocket Is A ‘Very Fine’ Company, Recommends Buying This Health Care Stock

Photo via Shutterstock